Inhibiting angiogenesis in these tumors, e.g., with anti-VEGF therapy, could act as a strategy to exacerbate tumor acidosis (Jain, 2014) and render the tumor more vulnerable to OXPHOS inhibitors. The gene discussed is VEGFA; the disease is neoplasm.